Literature DB >> 33528000

The actinomycin D molecule docks to a hydrophilic section of the SOX2 high-mobility group (HMG) domain.

Steven Lehrer1, Peter H Rheinstein2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33528000      PMCID： PMC7992875          DOI： 10.1093/neuonc/noaa299

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

Authors:  Oleg Trott; Arthur J Olson
Journal:  J Comput Chem       Date:  2010-01-30       Impact factor: 3.376

Review 3.  SOX2 in development and cancer biology.

Authors:  Daniel Novak; Laura Hüser; Jonathan J Elton; Viktor Umansky; Peter Altevogt; Jochen Utikal
Journal:  Semin Cancer Biol       Date:  2019-08-11       Impact factor: 15.707

4.  Actinomycin D: a new opening for an old drug.

Authors:  Gaetano Finocchiaro
Journal:  Neuro Oncol       Date:  2020-09-29       Impact factor: 12.300

Review 5.  SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond.

Authors:  Thorsten Schaefer; Claudia Lengerke
Journal:  Oncogene       Date:  2019-09-02       Impact factor: 9.867

6.  The Sox2 transcription factor binds RNA.

Authors:  Zachariah E Holmes; Desmond J Hamilton; Taeyoung Hwang; Nicholas V Parsonnet; John L Rinn; Deborah S Wuttke; Robert T Batey
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919

7.  Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma.

Authors:  Jessica T Taylor; Stuart Ellison; Alina Pandele; Shaun Wood; Erica Nathan; Gabriella Forte; Helen Parker; Egor Zindy; Mark Elvin; Alan Dickson; Kaye J Williams; Konstantina Karabatsou; Martin McCabe; Catherine McBain; Brian W Bigger
Journal:  Neuro Oncol       Date:  2020-09-29       Impact factor: 12.300
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.